These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15963113)

  • 1. The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer.
    Jain S; Kockelbergh RC
    BJU Int; 2005 Jul; 96(1):17-21. PubMed ID: 15963113
    [No Abstract]   [Full Text] [Related]  

  • 2. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
    Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
    Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence diagnosis of bladder cancer.
    Chatterton K; Ray E; O'Brien TS
    Br J Nurs; 2006 Jun 8-21; 15(11):595-7. PubMed ID: 16835527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Editorial comment on Stepp H. et al.: fluorescence diagnosis and photodynamic therapy in urology].
    Jocham D
    Aktuelle Urol; 2007 Nov; 38(6):453-4. PubMed ID: 17987532
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of the photodynamic method in the diagnosis of superficial bladder tumors].
    Lipiński MI; Jeromin LM
    Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma?
    Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW
    BJU Int; 2005 Jun; 95(9):1215-8. PubMed ID: 15892804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
    Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
    BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy.
    Zaak D; Karl A; Knüchel R; Stepp H; Hartmann A; Reich O; Bachmann A; Siebels M; Popken G; Stief C
    BJU Int; 2005 Aug; 96(2):217-22. PubMed ID: 16001963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of hematoporphyrin derivative (HpD) in the localization and treatment of transitional cell carcinoma (TCC) of the bladder.
    Benson RC
    Prog Clin Biol Res; 1984; 170():795-804. PubMed ID: 6241716
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.
    Zaak D; Frimberger D; Stepp H; Wagner S; Baumgartner R; Schneede P; Siebels M; Knüchel R; Kriegmair M; Hofstetter A
    J Urol; 2001 Nov; 166(5):1665-8; discussion 1668-9. PubMed ID: 11586198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer.
    Bunce C; Ayres BE; Griffiths TR; Mostafid H; Kelly J; Persad R; Kockelbergh R
    BJU Int; 2010 Feb; 105 Suppl 2():2-7. PubMed ID: 20089091
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fluorescence diagnosis and photodynamic therapy in urology].
    Stepp H; Waidelich R
    Aktuelle Urol; 2007 Nov; 38(6):455-64. PubMed ID: 17987533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluorescence technique on diagnosis of urinary bladder carcinoma].
    Hao GY; Zhang YH
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(19):1725-8. PubMed ID: 14723217
    [No Abstract]   [Full Text] [Related]  

  • 15. The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer.
    Dindyal S; Nitkunan T; Bunce CJ
    Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):153-8. PubMed ID: 19356647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic applications in superficial bladder cancer: facts and hopes!
    Jichlinski P
    J Environ Pathol Toxicol Oncol; 2006; 25(1-2):441-51. PubMed ID: 16566734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment.
    Scarpa RM; Cracco CM
    Urology; 2009 Dec; 74(6):1286-7; author reply 1287-8. PubMed ID: 19962530
    [No Abstract]   [Full Text] [Related]  

  • 18. Photodynamic therapy for superficial bladder cancer.
    Shackley DC; Briggs C; Whitehurst C; Betts CD; O'Flynn KJ; Clarke NW; Moore JV
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):523-30. PubMed ID: 12113084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.
    Kamuhabwa A; Agostinis P; Ahmed B; Landuyt W; van Cleynenbreugel B; van Poppel H; de Witte P
    Photochem Photobiol Sci; 2004 Aug; 3(8):772-80. PubMed ID: 15295634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved detection and reduced early recurrence of non-muscle-invasive bladder cancer using hexaminolaevulinate fluorescence cystoscopy: results of a multicentre prospective randomized study (PC B305).
    Mostafid H; Bunce C;
    BJU Int; 2009 Oct; 104(7):889-90. PubMed ID: 19549121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.